Calif. grand jury details EHR implementation problems

Laura Pedulli | | Health Exec | EMR/EHR

A California county's EHR implementation resulted in inefficient and delayed patient care as the organization did not devote adequate resources to its rollout, a county grand jury report concluded.

Ventura County Health Care Agency (VCHCA) went live in July 2013 at two hospitals and 40 clinics in the county. In its investigation, the grand jury learned that the EHR vendor for the project had recognized that VCHCA’s system had insufficient sources to carry out the implementation. For example, VCHCA had inefficient ordering of hardwire required for the project; insufficient support staff; insufficient training on the new system; lacked an experienced project manager; and failed to develop a standard project plan for the implementation.

Moving forward, the grand jury recommended that Ventura County develop better processes for capital projects.

Following the release of the report, VCHCA Director Barry Fisher said that the situation is much different today, as many improvement have been made. “Where we are at today is night and day from where we started,” he told the Ventura County Star.

Read the full report here.

Laura Pedulli

Related Content

Christmas ransomware exposed over 300K patient records to dark web
Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.